This site is intended for healthcare professionals
News

Myovant Sciences presents additional data on bone mineral density in women with uterine fibroids from phase III LIBERTY program of relugolix combination therapy.

Read time: 2 mins
Last updated:15th Sep 2020
Published:15th Sep 2020
Condition: Uterine Fibroids
Type: drug
Register free for full access to medthority.com